
Prostate Cancer
On this page
Why choose UCSF Health for prostate cancer treatment?
For more than 30 years, experts at UCSF Health have set the standard for prostate cancer care and are now shaping the future of the field. As the top NIH-funded urology research program in the country, we translate the newest discoveries into better care for our patients.
Our highly experienced doctors and other specialized providers treat all stages of prostate cancer with a focus on preserving your length and quality of life. UCSF Health also offers many clinical trials, which give our patients access to breakthrough treatments that are not yet widely available.
Why choose UCSF Health for prostate cancer treatment?
For more than 30 years, experts at UCSF Health have set the standard for prostate cancer care and are now shaping the future of the field. As the top NIH-funded urology research program in the country, we translate the newest discoveries into better care for our patients.
Our highly experienced doctors and other specialized providers treat all stages of prostate cancer with a focus on preserving your length and quality of life. UCSF Health also offers many clinical trials, which give our patients access to breakthrough treatments that are not yet widely available.
High-volume program
We are one of the highest-volume prostate cancer programs in Northern California, giving us a level of experience that leads to better outcomes.Collaborative approach
Urologic cancer surgeons work with genitourinary oncologists, radiation oncologists and other specialists to deliver coordinated care.Clinical trials
We study new ways to treat prostate cancer, such as using immunotherapy before surgery, to reduce the risk of cancer recurring (coming back.)Pioneering research
We were an early advocate of active surveillance for prostate cancer and are leaders in genomic testing to analyze genes in cancer cells to make treatments more targeted.
Personalized prostate cancer care
Our prostate cancer specialists design treatment plans to meet your needs and preferences. Whenever possible, we choose therapies that minimize side effects, such as urinary, bowel or sexual dysfunction.
Early detection and diagnosis
We focus on finding prostate cancer early, when it's easier to treat. Our diagnostic team includes radiologists and pathologists with specialized training in genitourinary cancer. We offer some of the most sophisticated diagnostic technology available, including advanced prostate MRI and prostate-specific membrane antigen (PSMA) PET scan.
UCSF Health researchers played a key role in obtaining FDA approval for the PSMA PET scan. A PSMA PET scan uses a radioactive tracer to locate prostate cancer with unparalleled precision, helping detect cancer that has spread (metastasized) earlier than ever before.
We are also pushing the boundaries of prostate cancer diagnosis and treatment through genomic and biomarker testing, including the UCSF500 Cancer Gene Panel and other advanced genomic tests. By examining cancer cells in your body for molecular or genetic changes, we can better predict which treatments will be most effective.
Our areas of expertise for prostate cancer treatment
We treat all stages of prostate cancer, from localized to advanced. Localized prostate cancer is confined to the prostate. Advanced cancer has spread to distant organs or lymph nodes.
Active surveillance
Low-risk prostate cancer is unlikely to spread and usually does not need treatment. In these cases, we use active surveillance to monitor you for any changes. This can include regular checkups, blood tests, genetic testing, imaging and prostate biopsies.
Focal therapy for prostate cancer
We are at the forefront of focal therapies for prostate cancer, which are treatments that use energy to destroy cancer cells. These noninvasive procedures target early-stage, localized tumors. Focal therapies avoid healthy prostate tissue, so they have fewer side effects than surgery or radiation therapy.
Our focal therapies include:
-
High-intensity focused ultrasound (HIFU). Destroys tumors using heat from ultrasound waves
-
Irreversible electroporation (IRE). Destroys cancer cells using electric pulses
-
Cryotherapy. Freezes and kills cancerous tissues
Robotic-assisted prostate cancer surgery
Urologic cancer surgeons at UCSF Health specialize in robotic prostatectomy — a minimally invasive surgery to remove the prostate using small incisions. Our expertise in this technique translates to a lower risk of sexual and urinary side effects. Patients also tend to have an easier recovery with less pain.
We are currently exploring new ways to identify tumors during robotic prostatectomy, including using a fluorescent substance that binds to prostate cancer cells and makes tumors light up during surgery. This can help our surgeons remove tumors with better accuracy and find metastases (tumors that have spread to other tissues) sooner.
Radiation therapy for prostate cancer
Our leading-edge radiation systems use imaging guidance to adjust the shape, angle and intensity of external radiation beams. This is especially important for prostate cancer because the prostate gland can change positions during treatment. We also offer internal radiation therapy, including high-dose rate (HDR) brachytherapy, where we place tiny radioactive seeds inside your body to directly target tumors.
Systemic therapies for prostate cancer
Your treatment plan may include systemic therapies, which are medications that circulate through your body. Systemic therapies may be appropriate for people with advanced prostate cancer or those who choose not to have surgery or radiation therapy.
Systemic therapies may include:
-
Chemotherapy. Shrinks prostate tumors and helps ease symptoms
-
Hormone therapy. Stops testosterone production, which prostate cancer cells need to live
-
Immunotherapy. Helps your immune system identify and attack cancer cells
-
Targeted therapy. Disrupts the processes that allow cancer cells to grow and divide
Providers

Peter Carroll, MD, MPH
Urologic Oncology
Matthew Cooperberg, MD, MPH
Urologic Oncology
Maxwell Meng, MD
Urologic Oncology
Hao Nguyen, MD
Urologic Oncology
Excellence in patient care
#1
in NIH funding for urology research

Best in California and No. 7 in the nation for cancer care

Best in Northern California for urology

Rated high-performing hospital for prostate cancer surgery
Related conditions & treatments
Conditions
- Erectile Disorder
- Prostate Cancer
- Localized Prostate Cancer
Treatments
- Active Surveillance of Prostate Cancer
- Androgen Deprivation Therapy
- Biological Targeted Therapy
- Brachytherapy
- Cancer Chemotherapy
- Cancer Immunotherapy
- Da Vinci Prostatectomy
- High-Intensity Focus Ultrasound for Prostate Cancer
- Prostate Cancer Cryotherapy
Prostate cancer education
Patient conference on prostate cancer
Clinical trials
A Phase 1 Safety and Efficacy Study of IS-002 Injection in Patients Undergoing Robotic Prostatectomy Using the da Vinci® Surgical System With Firefly® Fluorescent ImagingOpens in a new window
This is a Phase 1, single-site, interventional clinical trial evaluating the safety and efficacy of IS-002 intravenous (IV) injection for fluorescent identification and delineation of the positive cancer margins and metastatic lymph nodes during prostatectomy surgery using the da Vinci® X/Xi Surgical System with Firefly® Fluorescent Imaging.A Randomized Clinical Trial of Exercise vs. Usual Care Among Men Opting for Active Surveillance for Prostate CancerOpens in a new window
The AS RCT study is a randomized controlled trial of 16-weeks aerobic exercise (home-based walking) vs. usual care among men with prostate cancer on active surveillance.A Randomized Controlled Trial of Diet & Exercise Interventions Among Men With Prostate Cancer - II (Prostate 8-II)Opens in a new window
The Prostate 8-II study is a 2-year randomized controlled trial of testing different combinations of educational and supportive tools related to diet and exercise to evaluate biological, clinical, and quality of life outcomes in men choosing radical prostatectomy as treatment for prostate cancer.A Phase 3 Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer
This is a randomized, open-label, three-arm, phase 3 study in men with biochemically recurrent prostate cancer and PSA doubling time ≤ 9 months at the time of study entry.177Lu-PSMA-617 and Pembrolizumab in Treating Patients With Metastatic Castration-Resistant Prostate Cancer
This phase Ib trial studies the dose and schedule of 177Lu-PSMA-617 and pembrolizumab in treating patients with castration-resistant prostate cancer that has spread to other places in the body.A Phase 1 Study of FOR46 in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
This study will test the safety and efficacy of FOR46 given every 21 days to patients with metastatic castration-resistant prostate cancer.NRG- GU 008: Randomized Phase III Trial Incorporating Abiraterone Acetate with Prednisone and Apalutamide and Advanced Imaging into Salvage Treatment for Patients with Node-Positive Prostate Cancer After Radical ProstatectomyOpens in a new window
This phase III trial studies how well adding apalutamide, abiraterone acetate, and prednisone to the usual hormone therapy and radiation therapy works compared to the usual hormone therapy and radiation therapy in treating patients with node-positive prostate cancer after surgery.
Accreditations & memberships

National Cancer Institute
The National Cancer Institute has designated UCSF Health a comprehensive cancer center, its highest ranking. This designation is awarded to centers that demonstrate scientific excellence and the ability to conduct cancer research across many disciplines.
Commission on Cancer
UCSF Health's cancer programs have been accredited by the American College of Surgeons' Commission on Cancer (CoC) since 1933. The CoC is a consortium of groups dedicated to improving cancer patients' survival and quality of life via research, education and better medical care.
National Comprehensive Cancer Network
UCSF is a member of the National Comprehensive Cancer Network, an alliance of the world's top cancer centers. The network brings together leaders in treatment and research to improve the quality, effectiveness and efficiency of cancer care.
Dealing with treatment side effects

Pelvic Muscle Exercises
Strengthening pelvic muscles through exercise can improve incontinence. Learn how to do pelvic muscle exercises, also known as Kegels.
Erectile Dysfunction Causes
Some conditions are risk factors for erectile dysfunction (ED), including diabetes and heart disease. See a list of conditions and medicines that can cause ED.
Penile Injections: A Patient Guide
Learn how to administer a penile injection and get answers to common questions, including how the injected medication produces an erection.
Patient education

Guide to Coping with Prostate Cancer
Learning you have prostate cancer can lead to a range of emotions. Understand how to cope with the diagnosis, find resources and lean on your support system.
Nutrition and Prostate Cancer
Good nutrition may reduce the incidence of prostate cancer and help reduce the risk of prostate cancer progression. Learn more.
Prostate Cancer Glossary
Use this glossary to understand medical terms associated with prostate cancer, including Decipher Prostate, hormone therapy and remission.




